Back

Primary prevention ICD implantation in non-ischemic cardiomyopathy patients: a retrospective analysis applying the 2023 Dutch Society of Cardiology Guidelines

30 March 2025 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Device therapy 2 Implantable Cardioverter-Defibrillator (ICD) EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Luuk Hopman

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

5 More presentations in this session

Presentation thumbnail
Predictors of late gadolinium enhancement image quality in patients with cardiac devices
Miss F. Amrani (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Adaptive versus conventional cardiac resynchronization therapy in asian heart failure patients with moderately wide QRS: primary results from the Mid-Q Response randomized trial
Doctor S. Park (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Conduction system versus right ventricular pacing for bradycardia treatment; 1 year outcomes of a prospective, randomized trial in patients with advanced AV disease
Doctor K. Curila (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
Accurate machine learning classification of atrial high rate events with automated implementation in remote monitoring
Doctor A. Thiyagarajah (Bordeaux, FR)
Abstract Slides Video
Presentation thumbnail
Use of entrainment and overpacing of atrial tachyarrhythmias through CIED in outpatient clinic setting in locating site and termination of AT. Our experience of feasibility and reliability.
Doctor G. Criscione (Leiden, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Device therapy 2
Video

The Event

Event poster

EHRA 2025

30 March - 1 April 2025
You may be interested in
thumbnail
Congress Presentation
ICD therapy is indicated for all patients with non-ischaemic cardiomyopathy and severely impaired LVEF: con
thumbnail
Congress Presentation
Cardiac magnetic resonance for prophylactic implantable-cardioVerter defibrillator therapy international registry in patients with ischemic cardiomyopathy
thumbnail
Congress Presentation
Primary prevention implantable cardioverter defibrillators are no longer indicated in non-ischaemic HFrEF: pro

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources